Page last updated: 2024-12-11
fusaproliferin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
fusaproliferin: isolated from Fusarium proliferatum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6506535 |
CHEMBL ID | 486177 |
MeSH ID | M0246756 |
Synonyms (5)
Synonym |
---|
fusaproliferin |
CHEMBL486177 |
C20591 |
(-)-fusaproliferin |
[(2s)-2-[(1s,3e,7e,11s,12e,15r)-11,17-dihydroxy-1,4,8,12-tetramethyl-18-oxo-16-bicyclo[13.3.0]octadeca-3,7,12,16-tetraenyl]propyl] acetate |
Research Excerpts
Overview
Fusaproliferin (FUS) is a mycotoxin that has toxic activity against brine shrimp, insect cells, and chicken embryos. Fusarium proliferatum is a widespread pathogen of cereals.
Excerpt | Reference | Relevance |
---|---|---|
"Fusaproliferin is a toxic sesterterpene isolated from Fusarium proliferatum, a widespread pathogen of cereals. " | ( Structure and absolute stereochemistry of fusaproliferin, a toxic metabolite from Fusarium proliferatum. Benedetti, E; Fogliano, V; Logrieco, A; Mannina, L; Randazzo, G; Ritieni, A; Santini, A, 1996) | 2 |
"Fusaproliferin (FUS) is a mycotoxin that has toxic activity against brine shrimp, insect cells, and teratogenic effects on chicken embryos." | ( Study of the cytotoxic activity of beauvericin and fusaproliferin and bioavailability in vitro on Caco-2 cells. Font, G; Meca, G; Prosperini, A; Ruiz, MJ, 2012) | 1.35 |
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
" The aim of this study was to determine the cytotoxicity of BEA and FUS in human epithelial colorectal adenocarcinoma HT-29 and Caco-2 cells, the transepithelial transport and the bioavailability using Caco-2 cells as a simulated in vitro gastrointestinal model of the human intestinal epithelium." | ( Study of the cytotoxic activity of beauvericin and fusaproliferin and bioavailability in vitro on Caco-2 cells. Font, G; Meca, G; Prosperini, A; Ruiz, MJ, 2012) | 0.63 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID400347 | Toxicity in Artemia salina | 1996 | Journal of natural products, Feb, Volume: 59, Issue:2 | Structure and absolute stereochemistry of fusaproliferin, a toxic metabolite from Fusarium proliferatum. |
AID376861 | Toxicity against Artemia salina larvae | 2000 | Journal of natural products, Aug, Volume: 63, Issue:8 | Biological characterization of fusapyrone and deoxyfusapyrone, two bioactive secondary metabolites of Fusarium semitectum. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (33)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (27.27) | 18.2507 |
2000's | 14 (42.42) | 29.6817 |
2010's | 9 (27.27) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.22
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.22) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 3 (9.09%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 30 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |